<?xml version="1.0" ?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:seo="http://purl.org/seo/elements/1.0/" version="2.0">
	<channel>
		<title>Alzai Health Corp. News Releases</title>
		<link>https://feeds.newsfilecorp.com/company/12450</link>
		<description>Latest news from Alzai Health Corp., as distributed by TMX Newsfile.</description>
		<language>en</language>
		<copyright>CopyRight (c) 2026, Newsfile Corp. All Rights Reserved.</copyright>
		<managingEditor>office@newsfilecorp.com (Newsfile Corp.)</managingEditor>
		<webMaster>office@newsfilecorp.com (Newsfile Corp.)</webMaster>
		<lastBuildDate>Sun, 15 Nov 2026 16:00:09 -0500</lastBuildDate>
		<image>
			<url>https://images.newsfilecorp.com/logos/12450.jpg</url>
			<title>Alzai Health Corp. News Releases</title>
			<link>https://feeds.newsfilecorp.com/company/12450</link>
		</image>
		<atom:link rel="self" type="application/rss+xml" href="https://feeds.newsfilecorp.com/company/12450"/>
		<item xml:lang="en">
			<title>ALZAI Health Corp. Enters into MOU with Quanterix Corporation to Advance Early Alzheimer's Disease Identification</title>
			<link>https://www.newsfilecorp.com/release/323880/ALZAI-Health-Corp.-Enters-into-MOU-with-Quanterix-Corporation-to-Advance-Early-Alzheimers-Disease-Identification</link>
			<description>Toronto, Ontario--(Newsfile Corp. - November 13, 2026) - ALZAI Health Corp. (TSXV: ALZI) (OTCQB: ALZIF) (FSE: H2F) ("ALZAI" or the "Company"), a healthcare technology company developing artificial intelligence-driven disease risk identification solutions, is pleased to announce that it has entered into a Memorandum of Understanding ("MOU") with Quanterix Corporation ("Quanterix"), a leader in ultra-sensitive biomarker detection and blood-based diagnostic testing, to explore collaboration...&lt;img src="https://api.newsfilecorp.com/newsinfo/323880/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Fri, 13 Nov 2026 06:00:00 -0500</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/323880</guid>
		</item>
		<item xml:lang="en">
			<title>Alzai Health Corp. Joins Alzheimer's Association Business Consortium to Advance Alzheimer's Research and Innovation</title>
			<link>https://www.newsfilecorp.com/release/322529/Alzai-Health-Corp.-Joins-Alzheimers-Association-Business-Consortium-to-Advance-Alzheimers-Research-and-Innovation</link>
			<description>Toronto, Ontario--(Newsfile Corp. - November 5, 2026) - ALZAI Health Corp. (TSXV: ALZI) (OTCQB: ALZIF) (FSE: H2F) ("ALZAI" or the "Company"), a healthcare technology company developing artificial intelligence-driven disease risk identification solutions, is pleased to announce that it has joined the Alzheimer's Association Business Consortium ("AABC"), an initiative of the Alzheimer's Association® focused on advancing Alzheimer's disease and dementia research through innovation, collaboration,...&lt;img src="https://api.newsfilecorp.com/newsinfo/322529/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Thu, 05 Nov 2026 06:00:00 -0500</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/322529</guid>
		</item>
		<item xml:lang="en">
			<title>Alzai Health Corp. Provides Update Regarding Marketing Services Agreement with Euro Digital Media</title>
			<link>https://www.newsfilecorp.com/release/322005/Alzai-Health-Corp.-Provides-Update-Regarding-Marketing-Services-Agreement-with-Euro-Digital-Media</link>
			<description>Toronto, Ontario--(Newsfile Corp. - November 2, 2026) - Alzai Health Corp. (TSXV: ALZI) (OTCQB: ALZIF) (FSE: H2F) (the "Company" or "ALZAI"), further to its news release dated August 17, 2026 news release regarding its entry into a marketing services agreement dated August 12, 2026 (the "Services Agreement") with Euro Digital Media Ltd. ("Euro Digital") (address: 71-75 Shelton Street, Covent Garden, London, UK WC2H 9JQ), pursuant to which Euro Digital will provide market awareness and digital...&lt;img src="https://api.newsfilecorp.com/newsinfo/322005/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Mon, 02 Nov 2026 06:00:00 -0500</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/322005</guid>
		</item>
		<item xml:lang="en">
			<title>ALZAI Health Corp. Posted for Trading On The OTCQB Venture Market</title>
			<link>https://www.newsfilecorp.com/release/319944/ALZAI-Health-Corp.-Posted-for-Trading-On-The-OTCQB-Venture-Market</link>
			<description>Toronto, Ontario--(Newsfile Corp. - October 20, 2026) - ALZAI Health Corp. (TSXV: ALZI) (OTCQB: ALZIF) (FSE: H2F) ("ALZAI" or the "Company"), a healthcare technology company developing artificial intelligence-driven disease risk identification solutions, is pleased to announce that its common shares are now quoted for trading on the OTCQB Venture Market ("OTCQB") in the United States under the symbol ALZIF.The OTCQB Venture Market, operated by OTC Markets Group Inc., is a U.S. marketplace for...&lt;img src="https://api.newsfilecorp.com/newsinfo/319944/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 20 Oct 2026 07:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/319944</guid>
		</item>
		<item xml:lang="en">
			<title>ALZAI Health Corp. Posted for Trading on the Frankfurt Stock Exchange</title>
			<link>https://www.newsfilecorp.com/release/312764/ALZAI-Health-Corp.-Posted-for-Trading-on-the-Frankfurt-Stock-Exchange</link>
			<description>Toronto, Ontario--(Newsfile Corp. - September 3, 2026) - ALZAI Health Corp. (TSXV: ALZI) (FSE: H2F) ("ALZAI" or the "Company"), a healthcare technology company developing artificial intelligence-driven disease risk identification solutions, is pleased to announce that its common shares are now posted for trading on the Frankfurt Stock Exchange ("FSE") under the symbol H2F.The Frankfurt Stock Exchange is one of Europe's leading securities trading venues, providing access to a broad base of...&lt;img src="https://api.newsfilecorp.com/newsinfo/312764/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Thu, 03 Sep 2026 06:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/312764</guid>
		</item>
		<item xml:lang="en">
			<title>Alzai Health Corp. Announces Marketing Services Agreement</title>
			<link>https://www.newsfilecorp.com/release/309880/Alzai-Health-Corp.-Announces-Marketing-Services-Agreement</link>
			<description>Toronto, Ontario--(Newsfile Corp. - August 17, 2026) - Alzai Health Corp. (TSXV: ALZI) (the "Company" or "ALZAI") announces that it has entered into a services agreement dated August 12, 2026 (the "Services Agreement") with Euro Digital Media Ltd. ("Euro Digital") (address: 71-75 Shelton Street, Covent Garden, London, UK WC2H 9JQ) pursuant to which Euro Digital will provide market awareness and digital marketing services to the Company.Under the terms of the Services Agreement, Euro Digital will...&lt;img src="https://api.newsfilecorp.com/newsinfo/309880/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Mon, 17 Aug 2026 06:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/309880</guid>
		</item>
		<item xml:lang="en">
			<title>ALZAI and Linus Health Explore AI-Driven Collaborations Aimed at Early Identification of Alzheimer's Disease Risk and Cognitive Impairment</title>
			<link>https://www.newsfilecorp.com/release/309159/ALZAI-and-Linus-Health-Explore-AIDriven-Collaborations-Aimed-at-Early-Identification-of-Alzheimers-Disease-Risk-and-Cognitive-Impairment</link>
			<description>Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - August 11, 2026) - ALZAI Health Corp. (TSXV: ALZI) is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with Linus Health, an AI-driven brain health company focused on early detection and proactive intervention. The companies intend to explore opportunities to use their complementary technologies to support earlier identification and assessment of Alzheimer's disease risk and cognitive impairment, as...&lt;img src="https://api.newsfilecorp.com/newsinfo/309159/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 11 Aug 2026 06:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/309159</guid>
		</item>
		<item xml:lang="en">
			<title>ALZAI Health Corp. Secures Exclusive Global License for AI-Driven Liver Disease Risk Identification Technology</title>
			<link>https://www.newsfilecorp.com/release/305754/ALZAI-Health-Corp.-Secures-Exclusive-Global-License-for-AIDriven-Liver-Disease-Risk-Identification-Technology</link>
			<description>Toronto, Ontario--(Newsfile Corp. - July 20, 2026) - ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce that it has entered into an exclusive worldwide license agreement (the "Agreement") with MOR Research Applications Ltd. ("MOR"), the technology transfer company of Clalit Health Services and Yeda Research, the technology transfer company of the Weizmann Institute of Science and Development Co. Ltd. ("Yeda"), for proprietary artificial intelligence-driven liver...&lt;img src="https://api.newsfilecorp.com/newsinfo/305754/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Mon, 20 Jul 2026 06:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/305754</guid>
		</item>
		<item xml:lang="en">
			<title>ALZAI Health Corp. Announces Validation of Its AI-Driven Alzheimers Disease Risk Screening Solution on Large-Scale U.S. Patient Data</title>
			<link>https://www.newsfilecorp.com/release/304030/ALZAI-Health-Corp.-Announces-Validation-of-Its-AIDriven-Alzheimers-Disease-Risk-Screening-Solution-on-LargeScale-U.S.-Patient-Data</link>
			<description>Toronto, Ontario--(Newsfile Corp. - July 6, 2026) - ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce the validation of its proprietary artificial intelligence-driven Alzheimer's disease risk identification models using a large-scale U.S. longitudinal healthcare dataset, representing a significant milestone in the Company's potential U.S. commercialization.The validation demonstrated that ALZAI's risk-stratification models achieved performance on-par with...&lt;img src="https://api.newsfilecorp.com/newsinfo/304030/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Mon, 06 Jul 2026 06:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/304030</guid>
		</item>
		<item xml:lang="en">
			<title>Alzai Health Corp. Signs Strategic U.S. Commercialization Agreement with Centauri Health Solutions to Advance AI-Driven Alzheimer's Risk Identification</title>
			<link>https://www.newsfilecorp.com/release/303723/Alzai-Health-Corp.-Signs-Strategic-U.S.-Commercialization-Agreement-with-Centauri-Health-Solutions-to-Advance-AIDriven-Alzheimers-Risk-Identification</link>
			<description>Toronto, Ontario--(Newsfile Corp. - July 2, 2026) - ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce that it has entered into a strategic teaming agreement (the "Agreement") with Centauri Health Solutions ("Centauri"), a leading U.S. healthcare technology company serving 60 million members through advanced mission-critical technology, data intelligence, and engagement solutions delivered to U.S. health plans, healthcare providers and health systems. Under the...&lt;img src="https://api.newsfilecorp.com/newsinfo/303723/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Thu, 02 Jul 2026 06:49:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/303723</guid>
		</item>
	</channel>
</rss>
